COLL: Collegium Pharmaceutical, Inc. Stock

by  •  • Comments Off on COLL: Collegium Pharmaceutical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 935.68
Enterprise Value ($M) 1,863.30
Book Value ($M) 234.43
Book Value / Share 7.30
Price / Book 3.99
NCAV ($M) -889.26
NCAV / Share -27.68
Price / NCAV -1.05

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.20

Liquidity (mrq)
Quick Ratio 1.12
Current Ratio 1.21

Balance Sheet (mrq) ($M)
Current Assets 507.70
Assets 1,631.39
Liabilities 1,396.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 631.45
Operating Income 166.98
Net Income 69.19
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 204.98
Cash from Investing -287.76
Cash from Financing -60.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-14 13G/A Rubric Capital Management LP 9.34 27.66
05-02 13G Pacer Advisors, Inc. 5.40
04-28 13G/A BlackRock, Inc. 15.60 -13.63
02-07 13G Invesco Ltd. 5.50
11-13 13G Principal Global Investors 5.42
11-13 13G Renaissance Technologies Llc 5.14

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES
2024-08-08 10-Q UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 33,748 121,640 27.74
2025-05-29 60,235 165,994 36.29
2025-05-28 31,109 158,731 19.60
2025-05-27 38,658 149,846 25.80

(click for more detail)

Similar Companies
CGEM – Cullinan Therapeutics, Inc. CGON – CG Oncology, Inc.
COGT – Cogent Biosciences, Inc. CPIX – Cumberland Pharmaceuticals Inc.
CRBU – Caribou Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io